Lincoln National Corp’s Alkermes ALKS Stock Holding History

Lincoln National Corp’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,300	Closed	-$249K	–	490
2018 Q1	$249K	Buy	+4,300	New	+$252K	0.01%	409

Other funds holding ALKS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lincoln National Corp's ALKS Position: Q2 2018 in Review

Lincoln National Corp sold out of Alkermes (ALKS) in Q2 2018, closing a stake of 4,300 shares — an estimated $249K sold.

Lincoln National Corp first reported a position in ALKS in Q1 2018 and held it in 1 quarter. The position peaked at $249K in Q1 2018. 243 funds tracked by Wall St. Rank hold ALKS as of Q2 2018.

Lincoln National Corp reported no remaining Alkermes position as of Q2 2018 after selling out during the quarter.
Lincoln National Corp sold 4,300 Alkermes shares in Q2 2018, an estimated $249K.
Lincoln National Corp first reported a position in Alkermes in Q1 2018 and held it in 1 quarter.
Lincoln National Corp's Alkermes position peaked at $249K in Q1 2018.
243 funds tracked by Wall St. Rank held Alkermes as of Q2 2018.

Based on Lincoln National Corp's 13F filing for Q2 2018, filed 8 Aug 2018.